We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£114.71
This is the most expensive it has ever been. Walk away.
£115 today · previous high £115 · all-time low £108
Springer Resistance to Immunotherapeutic Antibodies in Cancer - Springer
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 70 days · 70 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 70 days • 2 price levels
Price Analysis
Most common price: £108 (69 days, 98.6%)
Price range: £108 - £115
Price levels: 2 different prices over 70 days
Description
Key Features
Focuses on monoclonal antibodies (mAbs) as selective anti-cancer agents that block specific cell receptors and target cancer cell-specific antigens.
Part of the Resistance to Targeted Anti-Cancer Therapeutics series, volume 2, offering comprehensive coverage of immunotherapeutic resistance.
Examines how antibody-mediated anti-cancer therapy reverses drug and radiation resistance while remaining less toxic than traditional treatments.
Published by Springer, providing peer-reviewed academic content for medical and healthcare practitioners specializing in internal medicine and immunology.
Addresses clinical strategies for overcoming resistance mechanisms in immunotherapy-based cancer treatment protocols.
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 1461476534
- Domain
- Amazon UK
- Release Date
- 05 August 2013
- Listed Since
- 04 April 2013
Barcode
No barcode data available
Similar Products You Might Like
Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
Elsevier
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
Humana
IL-1 in Cancer and Inflammation - Academic Press Medical Book
Elsevier
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Elsevier
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Elsevier
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
Springer
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
Springer
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
Elsevier
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
Humana
Elsevier Basic Immunology 7th Edition - Medical Text
Elsevier
Cancer Immunosurveillance: Methods and Protocols - Vol. 1884
Humana
Immunotherapy of Cancer: Innovative Treatment Comes of Age
Springer
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
Humana
Regulatory B Cells: Methods and Protocols: 1190 (Methods in Molecular Biology)
Humana
Immune Receptors: Methods and Protocols - Molecular Biology
Humana
Wiley A Beginner's Guide to Targeted Cancer Treatments
Wiley
Advances in Immunology: 95: Volume 95
Elsevier
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
Springer
Advances in Immunology: 92: Volume 92
Elsevier
Advances in Immunology: v. 96: Volume 96
Elsevier
Advances in Immunology: Volume 149
Elsevier
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
CRC Press